-
05/04/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized
Advisory or Update, COVID-19, Health Advisory, News and Alerts, Novel Coronavirus, Provider Resources, VaccineRequested actions Monovalent Moderna and Pfizer COVID-19 vaccines are no longer authorized for use in the United States. Read below for how to discard and report as waste. Use the new simplified schedule to administer COVID-19 vaccine. People who are 65 years or older or have immune compromise can now get a second bivalent booster … 05/04/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized
-
04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses second COVID-19 booster dose eligibility
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Immunization, Infection Control, MERS-CoV, News and Alerts, News and Update, Notifiable Conditions, Novel Coronavirus, Provider Resources, VaccineRequested actions Be aware, on April 25, 2022, Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) advisory about the availability and use of recommended COVID-19 therapies. It also advised against using unproven treatments that have known or potential harm. Follow National Institutes of Health (NIH) COVID-19 treatment guidelines and use … 04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses second COVID-19 booster dose eligibility
-
04/08/22 Health Advisory: COVID-19 Information for Providers
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, News and Alerts, Notifiable Conditions, Provider ResourcesRequested actions Be aware, on March 29, 2022, Food and Drug Administration (FDA) amended its emergency use authorization (EUA) for Moderna COVID-19 booster dose vaccine. A new multi-dose vial is now available. It has a dark blue cap and a label with a purple border. Doses from this vial are 0.5 mL. Multi-dose vials are … 04/08/22 Health Advisory: COVID-19 Information for Providers
-
Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups
Requested Actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup endorsed Food and Drug Administration’s (FDA’s) emergency use authorization (EUA) of a second booster dose of Pfizer or Moderna COVID-19 vaccines for specific groups. The EUA allows: A second booster dose of Pfizer COVID-19 vaccine at least … Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups
-
03/30/22 Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, News and Alerts, Notifiable Conditions, Provider ResourcesRequested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup endorsed Food and Drug Administration’s (FDA’s) emergency use authorization (EUA) of a second booster dose of Pfizer or Moderna COVID-19 vaccines for specific groups. The EUA allows: A second booster dose of Pfizer COVID-19 vaccine at least … 03/30/22 Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups
-
FDA Issued Emergency Use Authorization for Pfizer’s Paxlovid
Requested Actions Be aware, the S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) … FDA Issued Emergency Use Authorization for Pfizer’s Paxlovid
-
Health Advisory: Increase in Syphilis Cases in Yakima County
Requested Actions Be aware, Yakima County reported a 326% increase in syphilis cases in 2021 compared to 2020. Optimize syphilis surveillance in pregnancy to reduce the risk of congenital syphilis. Test all women in the first trimester or at presentation to care if presenting after the first trimester Test all high-risk women again in the … Health Advisory: Increase in Syphilis Cases in Yakima County
-
03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings
Advisory or Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesRequested actions Be aware, on March 4, Washington State Department of Health (DOH) discontinued ordering Johnson & Johnson COVID-19 vaccine because inventory is very low at Centers for Disease Control and Prevention (CDC) in Washington Immunization Information System (IIS). We encourage providers to post and look for available doses on IIS vaccine advertisement page. Email … 03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings
-
02/25/22 Health Advisory: COVID-19 Updates for Providers
Requested actions Be aware, on Feb. 22, Centers for Disease Control and Prevention (CDC) revised its COVID-19 vaccine clinical considerations. An 8-week interval between first and second doses of mRNA COVID-19 vaccine (Moderna and Pfizer) may be optimal for males 12–39 years old to reduce risk of myocarditis and increase efficacy. CDC still recommends a … 02/25/22 Health Advisory: COVID-19 Updates for Providers
-
02/14/22 Health Advisory: CDC Updated Covid-19 Vaccination Guidelines; FDA Postponed its pediatric Covid-19 Vaccination Review
COVID-19 Updates for Providers Requested actions Be aware, on February 11, the Centers for Disease Control and Prevention updated their guidance for COVID-19 vaccination to include: For people who are moderately or severely immunocompromised: People who have completed a primary series of an mRNA vaccine (Pfizer-BioNTech or Moderna) are recommended to receive an mRNA booster … 02/14/22 Health Advisory: CDC Updated Covid-19 Vaccination Guidelines; FDA Postponed its pediatric Covid-19 Vaccination Review
-
Urgent Notice: New Communicable Disease Fax Line
Communicable Disease Data Report, Health Alert, News and Alerts, News and Update, Notifiable ConditionsThe Communicable Disease department at the Yakima Health District has a new fax line to report notifiable conditions and communicable diseases. The new fax line is (509) 381-3526. The Yakima Health District investigates approximately 100 communicable diseases and conditions that are reportable to the local health jurisdiction. To report a notifiable condition, use the Notifiable … Urgent Notice: New Communicable Disease Fax Line
-
Uninsured Care Expansion Grant and Patient Resources for Individuals Experiencing Long COVID-19
Requested Actions Be aware the Health Care Authority (HCA) has received $35 million in federal resources for the provision of health care services for uninsured and underinsured individuals under 200 percent of the federal poverty level, regardless of immigration status. Be aware the University of Washington Medicine has a Post-COVID-19 Rehabilitation and Recovery clinic to … Uninsured Care Expansion Grant and Patient Resources for Individuals Experiencing Long COVID-19
-
02/01/22 Health Advisory: FDA Provides Full Approval For Spikevax
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Notifiable Conditions, Provider Resources, UncategorizedCOVID-19 Updates for Providers Requested actions Be aware, U.S. Food and Drug Administration (FDA) granted full authorization to Moderna COVID-19 vaccine for people 18 years or older. Evidence shows the vaccine is safe and effective and manufactured with high quality. The vaccine will now be called Spikevax but has the same formulation as emergency use … 02/01/22 Health Advisory: FDA Provides Full Approval For Spikevax